Showing results (171-180 of 179) with videos related to
Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
Journal of the American Chemical Society|June 22, 2026
Pressure-Induced Superconductivity in the Thermoelectric Semiconductor Mg<sub>3</sub>Sb<sub>2</sub>Cuiying Pei, Yasong Wu, Airan Li, et al.Neurobiology of Aging|August 3, 2014
Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 miceFei Wang, Hanqiu Liu, Xueyan Shen, et al.Paediatric and Perinatal Epidemiology|September 1, 2021
Incidence of retinopathy of prematurity treatment in extremely preterm infants in ChinaYi Dai, Li Zhu, Yequn Zhou, et al.Signal Transduction and Targeted Therapy|July 20, 2025
Differential expression pattern of CC chemokine receptor 7 guides precision treatment of hepatocellular carcinomaJie Qin, Qianyi Gong, Cheng Zhou, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 9, 2023
Pressure-Induced Superconductivity and Topological Quantum Phase Transitions in the Topological Semimetal ZrTe<sub>2</sub>Shihao Zhu, Juefei Wu, Peng Zhu, et al.BMJ Open|May 18, 2026
Chiglitazar in combination with anti-inflammatory and hepatoprotective therapy for the treatment of MASH associated with T2DM: a prospective, multicentre, randomised, double-blind, placebo-controlled study protocolKai He, Fengyuan Chen, Rong Shao, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 6, 2025
Subthalamic deep brain stimulation in isolated generalised or segmental dystonia (RELAX Study): a multicentre, randomised, double-blind, controlled trialLin Wang, Huifang Shang, Lingjing Jin, et al.BMC Medicine|December 4, 2025
Genomic pathogenic alterations in the SWI/SNF complex compromise the outcomes of immunotherapy in Chinese patients with KRAS-mutant NSCLC by downregulating STING expressionLingling Gao, Jie Jiang, Linlin Zhu, et al.Nature Medicine|August 2, 2024
The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trialIokfai Cheang, Wenming Yao, Yanli Zhou, et al.Pageof 18